ADAR and cervical carcinoma: In addition, 71.43% (20/28) cervical cancer specimens demonstrated higher expression of ADAR1 than their matched tumor specimens, and the percentage of cancerous specimen overexpression of ADAR2 was 64.29% (18/28).